# Varenicline + Prazosin for Heavy Drinking Smokers

> **NCT02193256** · EARLY_PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 5 (actual)

## Conditions studied

- Cigarette Smoking
- Alcohol Use Disorders

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Prazosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02193256
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-01
- **Final completion:** 2015-06
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2020-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193256, "Varenicline + Prazosin for Heavy Drinking Smokers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02193256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*